clinical pharmacology China – Clinical Research Made Simple

Bioequivalence Trials for Generics in China: Case Examples

October 17, 2025

Bioequivalence Trials for Generics in China: Case Examples Conducting Bioequivalence Trials for Generics in China: Practical Case Examples Introduction Bioequivalence (BE) trials are essential for the approval of generic drugs, ensuring that the generic product demonstrates comparable safety and efficacy to its reference drug. In China, the National Medical Products Administration (NMPA) has established detailed…

Clinical Trials in China, Country-Specific Clinical Trials

Clinical Pharmacology Studies in China: A Regulatory Perspective

October 7, 2025

digi

Clinical Pharmacology Studies in China: A Regulatory Perspective Regulatory Insights into Clinical Pharmacology Studies in China Introduction Clinical pharmacology studies form the foundation of drug development, generating essential data on pharmacokinetics (PK), pharmacodynamics (PD), bioavailability, and bioequivalence. In China, these studies have gained increasing regulatory importance as the National Medical Products Administration (NMPA) has modernized…

Clinical Trials in China, Country-Specific Clinical Trials